Cyclophilin D
Cyclophilin D
Cyclophilin D (CypD) is a mitochondrial matrix protein that plays a crucial role in the regulation of the mitochondrial permeability transition pore (mPTP). It is a member of the cyclophilin family of peptidyl-prolyl isomerases, which are enzymes that catalyze the cis-trans isomerization of proline imidic peptide bonds in proteins, facilitating protein folding.
Structure[edit | edit source]
Cyclophilin D is encoded by the PPIF gene in humans. The protein consists of a single domain that is characteristic of cyclophilins, which includes a conserved region responsible for its peptidyl-prolyl isomerase activity. The structure of Cyclophilin D allows it to interact with other components of the mPTP, such as the adenine nucleotide translocase (ANT) and the voltage-dependent anion channel (VDAC).
Function[edit | edit source]
Cyclophilin D is primarily located in the mitochondrial matrix, where it regulates the opening of the mPTP. The mPTP is a non-specific channel that spans the inner mitochondrial membrane and is involved in the regulation of mitochondrial membrane potential and cell death pathways. Under normal physiological conditions, the mPTP remains closed, but it can open in response to increased calcium levels, oxidative stress, or other pathological stimuli.
The opening of the mPTP leads to the loss of mitochondrial membrane potential, swelling of the mitochondria, release of pro-apoptotic factors, and ultimately cell death. Cyclophilin D modulates the sensitivity of the mPTP to these stimuli, and its inhibition has been shown to protect against cell death in various models of ischemia-reperfusion injury and neurodegenerative diseases.
Clinical Significance[edit | edit source]
Cyclophilin D has been implicated in a variety of diseases, including cardiovascular disease, neurodegenerative disorders, and cancer. Inhibition of Cyclophilin D has been proposed as a therapeutic strategy to prevent cell death in conditions such as myocardial infarction and stroke. Additionally, Cyclophilin D is a target for the immunosuppressive drug cyclosporine, which binds to cyclophilins and inhibits their isomerase activity.
Research[edit | edit source]
Recent studies have focused on the development of specific inhibitors of Cyclophilin D that do not affect other cyclophilins, in order to minimize side effects. The role of Cyclophilin D in the regulation of mitochondrial dynamics and its interaction with other mitochondrial proteins is an active area of research.
Also see[edit | edit source]
- Mitochondrial permeability transition pore
- Peptidyl-prolyl isomerase
- Mitochondria
- Cell death
- Cyclosporine
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD